Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Tocris Bioscience™ ESI 09

Epac inhibitor

Supplier:  Tocris Bioscience™ 4773/10

 View more versions of this product

Catalog No. 477310


Add to Cart
This item is not returnable. View return policy

Description

Description

ESI 09 is an EPAC inhibitor. Inhibits EPAC-mediated insulin release from pancreatic β cells. Selective for EPAC over PKA. ESI 09 decreases migration and invasion of AsPc-1 and PANC-1 pancreatic cancer cells in vitro.
Specifications

Specifications

EPAC Inhibitors
α-[(2-(3-Chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-β-oxo-3-isoxazolepropanenitrile
Soluble to 100mM in DMSO and to 20mM in ethanol
330.77
Bioactive Small Molecule
263707-16-0
10 mg
C16H15ClN4O2
Solid
>98%
Product Suggestions

Product Suggestions

Safety and Handling

Safety and Handling

Recommended Storage : Store at 4°C

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

Research Use Only. Not For Human or Veterinary Use